A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose ...
Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.
Kuwait Times on MSN
Dexcom G7 launched in Kuwait
KUWAIT: Dexcom, a global leader in continuous glucose monitoring (CGM), has officially launched the Dexcom G7 in Kuwait in partnership with the Central Circle Company. On the sidelines of the event, ...
Continuous glucose monitoring (CGM) is underutilized in non-insulin-treated type 2 diabetes (T2D) despite evidence of ...
Automated insulin delivery systems — a continuous glucose monitor, insulin pump, and algorithm — enable athletes to manage ...
Zacks Investment Research on MSN
PODD stock benefits from FDA approval of Omnipod 5's enhancements
Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...
The device is the first diabetic monitoring system built specifically for veterinary use on these animals, said ALR ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Touchstone Mid Cap Growth Fund outperformed its benchmark in Q3 2025 despite speculative markets. Discover key drivers and ...
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results